Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

Documenti analoghi

• Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
  di: Gerretsen, M., et al.
  Pubblicazione: (1991)
• Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
  di: de Bree, R., et al.
  Pubblicazione: (1997)
• A 22-kd surface antigen detected by monoclonal antibody E 48 is exclusively expressed in stratified squamous and transitional epithelia.
  di: Quak, J. J., et al.
  Pubblicazione: (1990)
• Radioimmunotherapy for Pancreatic Carcinoma Using (131)I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
  di: Inui, Akimasa, et al.
  Pubblicazione: (1996)
• Fractionated (131)I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice
  di: Violet, J A, et al.
  Pubblicazione: (2008)